Doug Doerfler

Title: Doug Doerfler: Innovator in Electroporation Technology

Introduction

Doug Doerfler is a notable inventor based in Darnestown, MD (US). He has made significant contributions to the field of biotechnology, particularly in the area of drug delivery systems. His innovative work focuses on methods that enhance the encapsulation of therapeutic substances into cells.

Latest Patents

Doug Doerfler holds a patent for a "Flow electroporation chamber and method." This invention relates to a method and apparatus designed for the encapsulation of substances and drugs into cells and platelets. The technology is particularly relevant for incorporating thrombus-dissolving drugs, such as tissue plasminogen activator and streptokinase, into platelets. The treated platelets can then be utilized to treat patients suffering from thrombus blockages in blood vessels. Additionally, the invention includes a preparation of red blood cells that exhibits a stable right shift of the oxygen dissociation curve. He has 1 patent to his name.

Career Highlights

Doug Doerfler is currently associated with Maxcyte Inc., a company that specializes in cell engineering and drug delivery technologies. His work at Maxcyte has positioned him as a key player in advancing therapeutic applications in the medical field.

Collaborations

Throughout his career, Doug has collaborated with esteemed colleagues, including John W. Holaday and Peter H. Meserol. These partnerships have contributed to the development and refinement of innovative technologies in biotechnology.

Conclusion

Doug Doerfler's contributions to the field of electroporation technology highlight his commitment to improving drug delivery systems. His innovative patent and work at Maxcyte Inc. demonstrate his significant impact on the biotechnology industry.